QIAGEN NV EO -,01 | 42.03 / +0.79% |
Date/Time | 03/02 / 14:44 |
Chg. / Chg.(%) | 0.33 / +0.79% |
Bid | 42.04 / 300 |
Ask | 42.05 / 300 |
Open | 41.59 |
Previous Close | 41.70 |
High | 42.22 |
Low | 41.50 |
Volume [EUR] | 228,896.71 |
Volume [Units] | 5,464 |
Price fixings | 53 |
ISIN | NL0012169213 |
Security | QIA |
Exchange | TradeGate |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 42.030 | ![]() |
159,551 |
Turquoise | 41.97 | ![]() |
70,865 |
Cboe Europe .. | 42.03 | ![]() |
56,104 |
London Inter.. | 42.00 | ![]() |
14,494 |
TradeGate | 42.03 | ![]() |
5,464 |
Stuttgart | 41.960 | ![]() |
2,110 |
Frankfurt | 42.1900 | ![]() |
1,550 |
gettex | 41.930 | ![]() |
440 |
Düsseldorf | 41.950 | ![]() |
265 |
Cboe Europe .. | 42.02 | ![]() |
62 |
Vienna Globa.. | 41.58 | ![]() |
0 |
München | 41.580 | ![]() |
0 |
Hamburg | 41.510 | ![]() |
0 |
Hannover | 41.510 | ![]() |
0 |
Berlin | 41.510 | ![]() |
0 |
Lang & Schwa.. | 42.020 | ![]() |
|
NYSE | 50.36 | ![]() |
706,409 |
IEX | 50.34 | ![]() |
14,147 |
Cboe US | 50.36 | 12,912 | |
Cboe Europe .. | 40.87 | 40 | |
EUREX | Options |
News
- OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12/09/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
11/10/2020 / 22:01 - GlobeNewswire - Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
10/06/2020 / 21:30 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
08/13/2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
08/11/2020 / 22:01 - GlobeNewswire
Personal area
Click on
to activate push quotes.
